We are live on ! Find out more
NBTX

Nanobiotix
NBTX

6 hedge funds and large institutions have $26M invested in Nanobiotix in 2022 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.11% less ownership

Funds ownership: 10.11% → 9.99% (-0.11%)

10% less capital invested

Capital invested by funds: $28.8M → $26M (-$2.8M)

14% less funds holding

Funds holding: 7 → 6 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
-$200K
2
Millennium Management
Millennium Management
New York
-$101K
3
UBS Group
UBS Group
Switzerland
-$17.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
Baillie Gifford & Co
1
Baillie Gifford & Co
United Kingdom
$10.5M – – –
PA
2
Perceptive Advisors
New York
$7.88M – – –
AG
3
Artal Group
Luxembourg
$7.44M – – –
WP
4
Woodline Partners
California
$121K -$200K -25,284 -59%
UBS Group
5
UBS Group
Switzerland
$26K -$17.4K -2,194 -36%
AWM
6
Activest Wealth Management
Florida
$2K – – –
Millennium Management
7
Millennium Management
New York
– -$101K -12,217 Closed

NBTX Hedge Fund Activity: Q1 2022 in Review

6 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Nanobiotix (NBTX) for Q1 2022, worth a combined $26M — down 9.7% from $28.8M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of NBTX and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.

The largest seller was Woodline Partners, cutting an estimated $200K.

  • 6 institutional investors held Nanobiotix (NBTX) as of Q1 2022, down from 7 in Q4 2021.
  • Funds reported $26M of Nanobiotix stock for Q1 2022, down 9.7% quarter-over-quarter.
  • 0 funds opened new Nanobiotix positions in Q1 2022 and 1 closed out, a net change of -1 holder.
  • The largest Nanobiotix seller in Q1 2022 was Woodline Partners, an estimated $200K sold.

Based on aggregated 13F filings for Q1 2022.